Demand For COVID Antibody Drugs Soars In Hard-Hit States

Posted by on August 20, 2021 5:50 pm
Categories: US National Stories

Regeneron monoclonal antibody drug treatment is in increased demand during the surge in illness driven by the coronavirus

The drugs are only recommended for people at the highest risk of severe COVID-19, but access has been broadened to include older people and those with obesity and diabetes.

(Image credit: Joe Cavaretta/AP)

Leave a Reply

Your email address will not be published. Required fields are marked *